ATE71833T1 - Labetalol tablette mit verzoegerter wirkstoffabgabe. - Google Patents

Labetalol tablette mit verzoegerter wirkstoffabgabe.

Info

Publication number
ATE71833T1
ATE71833T1 AT87116021T AT87116021T ATE71833T1 AT E71833 T1 ATE71833 T1 AT E71833T1 AT 87116021 T AT87116021 T AT 87116021T AT 87116021 T AT87116021 T AT 87116021T AT E71833 T1 ATE71833 T1 AT E71833T1
Authority
AT
Austria
Prior art keywords
labetalol
delayed
release tablet
hydroxypropylmethylcellulose
polyvinylpyrrolidone
Prior art date
Application number
AT87116021T
Other languages
English (en)
Inventor
Surendra Sangekar
Winston A Vadino
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE71833T1 publication Critical patent/ATE71833T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87116021T 1986-11-03 1987-10-31 Labetalol tablette mit verzoegerter wirkstoffabgabe. ATE71833T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92630686A 1986-11-03 1986-11-03
EP87116021A EP0266707B1 (de) 1986-11-03 1987-10-31 Labetalol Tablette mit verzögerter Wirkstoffabgabe

Publications (1)

Publication Number Publication Date
ATE71833T1 true ATE71833T1 (de) 1992-02-15

Family

ID=25453030

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87116021T ATE71833T1 (de) 1986-11-03 1987-10-31 Labetalol tablette mit verzoegerter wirkstoffabgabe.

Country Status (5)

Country Link
EP (1) EP0266707B1 (de)
JP (1) JPS63126825A (de)
AT (1) ATE71833T1 (de)
DE (1) DE3776269D1 (de)
GR (1) GR3003745T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2723919B2 (ja) * 1988-09-02 1998-03-09 エーザイ株式会社 環状アミン誘導体を含有する経口用医薬品組成物
IT1229856B (it) * 1989-04-20 1991-09-13 Recordati Chem Pharm Compresse a rilascio controllato contenenti flavossato.
DE4001622A1 (de) * 1990-01-20 1991-07-25 Thomae Gmbh Dr K Orale arzneimittelformen von pimobendan
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
CZ291495B6 (cs) 1992-09-18 2003-03-12 Yamanouchi Pharmaceutical Co., Ltd. Hydrogelotvorný farmaceutický přípravek s prodlouženým uvolňováním
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
JOP20220209A1 (ar) * 2020-03-09 2023-01-30 Sushma Paul Berlia تركيبات الإطلاق المحكوم مشتملة على الدروتافيرين أو ملحه
CN117045610B (zh) * 2023-08-24 2024-04-30 杭州沐源生物医药科技有限公司 一种溶出高稳定性的盐酸拉贝洛尔组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1555958A (en) * 1976-02-27 1979-11-14 Allen & Hanburys Ltd Amino hydroxyethyl salicylamides processes for their preparation and compositions containing them
GB2181053B (en) * 1985-10-01 1990-05-23 Sandoz Ltd Pharmaceutical formulations with controlled release of the active substance
FR2588188B1 (fr) * 1985-10-04 1988-01-08 Delalande Sa Comprime de sel(s) hydrosoluble(s) de cinepazide a liberation programmee et son procede de preparation

Also Published As

Publication number Publication date
GR3003745T3 (de) 1993-03-16
DE3776269D1 (de) 1992-03-05
EP0266707A2 (de) 1988-05-11
EP0266707B1 (de) 1992-01-22
JPS63126825A (ja) 1988-05-30
EP0266707A3 (en) 1989-05-03

Similar Documents

Publication Publication Date Title
SI0642788T1 (en) Tramadol salt containing medicaments with sustained release of the active ingredient
MY100721A (en) Therapeutic agent.
DK383987D0 (da) Ny galeniske formuleringer med programmeret afgivelse indeholdende antiphlogistika
ATE78157T1 (de) Arzneimittel mit langsamer freisetzung.
ITMI912024A1 (it) Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
CA2034096A1 (en) Controlled absorption naproxen formulation for once-daily administration
DE69105040D1 (de) Arzneimittel gegen Impotenz.
ITMI913170A0 (it) Composizione farmaceutica per uso oftalmico contenente un antinfiammatorio non steroideo ed un decongestionante come principi attivi
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
ATE71833T1 (de) Labetalol tablette mit verzoegerter wirkstoffabgabe.
RU94002133A (ru) 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство
RU98111152A (ru) Применение активного вещества флупиртина или его фармакологически приемлемых солей в качестве лекарственного средства для профилактики и лечения заболеваний, ассоциированных с повреждением клеточной системы гемопоэза
IT8622082A0 (it) Preparato farmaceutico a base di buflomedil cloridrato, sotto formadi compresse a rilascio controllato e relativo procedimento di preparazione.
ITBO930460A0 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.
DK493887A (da) Buccal formulering
FR2715849B1 (fr) Forme d'administration solide à délitescence rapide d'un principe actif.
ITBO930294A1 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato/ ritardato del principio attivo e le forme farmaceutiche cosi' ottenute
ITBO920455A0 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato ritardato del principio attivo e le forme farmaceutiche cosi' ottenu- te.
ATE130190T1 (de) Ein dihydropyridinderivat in nanosolform enthaltendes retard-arzneimittel und seine herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee